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Abstract A decrease in constitutive NO synthase (cNOS)
activity and an increase in inducible NO synthase (iNOS)
activity occurred with an increase in myeloperoxidase (MPO)
activity, an index of neutrophil infiltration, in the gastric mucosa
of rats with water immersion restraint (WIR) stress. This
increase in gastric mucosal MPO activity was enhanced by
pretreatment with NG-monomethyl L-arginine, a non-selective
NOS inhibitor, but was prevented with maintenance of gastric
mucosal cNOS activity by pretreatment with aminoguanidine, a
selective iNOS inhibitor. The MPO activity was negatively
correlated with the cNOS activity in all WIR-stressed rats used
(r =30.723). These results suggest that a decrease in cNOS
activity could contribute to an increase in neutrophil infiltration
in the gastric mucosa of WIR-stressed rats.
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1. Introduction
It has been suggested that neutrophil in¢ltration into gastric
mucosal tissues is a critical process in the pathogenesis of a
variety of gastric ulcers [1^7]. Our previous study has demon-
strated that neutrophil in¢ltration into gastric mucosal tissues
is involved in the development of acute gastric mucosal lesions
in rats with water immersion restraint (WIR) stress [8].
Nitric oxide (NO) is a biologically active substance which is
produced from L-arginine via a Ca2-dependent constitutive
NO synthase (cNOS) or a Ca2-independent inducible NO
synthase (iNOS) [9]. Both NO synthases have been detected
in gastric mucosal tissues of rats histochemically [10] and bio-
chemically [11^13]. It has been widely accepted that in the
digestive system, NO produced by cNOS is cytoprotective,
while excessive NO produced by iNOS is cytotoxic [14]. Re-
cently, we have reported that in rats with WIR stress, a de-
crease in cNOS activity and an increase in iNOS activity in
the gastric mucosa occurs with the development of gastric
mucosal lesions [13]. These changes in gastric mucosal
cNOS and iNOS activities with the development of gastric
mucosal lesions in rats with WIR stress seem to be consistent
with the above-mentioned proposal.
It has been demonstrated that NOS inhibitors such as NG-
monomethyl L-arginine (L-NMMA) and NG-nitro-L-arginine
methyl ester (L-NAME) promote leukocyte-endothelial cell
adhesive interactions and leukocyte emigration in postcapil-
lary venules [15]. It has also been shown that L-NAME-in-
duced leukocyte adhesion in postcapillary venules is inhibited
by L-arginine, a precursor for NO [15], or nitroprusside, an
NO donor [16]. These ¢ndings have suggested that NO should
play an inhibitory role in neutrophil in¢ltration into tissues.
The above-mentioned ¢ndings may allow us to assume that
a change in NO production in the gastric mucosa of rats with
WIR stress a¡ects neutrophil in¢ltration into the gastric mu-
cosa, resulting in the development of gastric mucosal lesions.
However, it is unclear at present whether or not changes in
gastric mucosal cNOS and iNOS activities contribute to neu-
trophil in¢ltration into the gastric mucosa of rats with WIR
stress. Therefore, we examined the relationship between the
changes of cNOS and iNOS activities and the change of mye-
loperoxidase (MPO) activity, a marker of neutrophil in¢ltra-
tion [17], in the gastric mucosa of WIR-stressed rats with and
without pretreatment of either L-NMMA, which is known to
inhibit both cNOS and iNOS [18], or aminoguanidine, a se-
lective inhibitor of iNOS [9,19].
2. Materials and methods
2.1. Chemicals
Tetramethylbenzidine, oxyhaemoglobin and aminoguanidine were
purchased from Sigma Chemical Co. (St. Louis, MO, USA); rabbit
anti-rat polymorphonuclear (PMN) antiserum from Inter-Cell Tech-
nologies, Inc. (Hopewell, NJ, USA); L-arginine, L-valine, NG-mono-
methyl L-arginine monoacetate (L-NMMA), NG-monomethyl D-argi-
nine monoacetate (D-NMMA), and other chemicals from Wako Pure
Chemicals Ind., Ltd. (Osaka, Japan).
2.2. Induction of gastric mucosal lesions
Seven-week-old male Wistar rats weighing 200^210 g purchased
from Shizuoka Laboratory Animal Center Co. (Hamamatsu, Japan),
were used. These animals were starved for 24 h prior to experiments,
but were allowed free access to water. Rats were restrained in a wire
cage and immersed up to the depth of the xiphoid process in a 23‡C
water bath for 1, 3 and 6 h to produce WIR stress-induced gastric
mucosal lesions as described by Takagi and Okabe [20]. Rats were
killed under ether anesthesia after application of 0, 1, 3, and 6 h of
WIR at which time stomachs were removed. The removed stomachs
were cut open along with the greater curvature and the gastric mucosa
was removed on ice using small scissors. For the observation of gas-
tric lesion, the stomachs of rats with and without WIR, after ligation
of the esophagus at 5 mm proximal to the gastroesophageal junction
and the duodenum at 10 mm distal to the pylorus, were infused with
approximately 10 ml of saline (50 ml/kg body weight) and secured by
ligatures at both esophagus and duodenum, and then the stomachs
were removed. The removed stomachs were ¢xed with 10% formalde-
hyde for 10 min and cut open along with the greater curvature. The
gastric mucosa was carefully examined, independently, by two observ-
ers in a blind manner, for lesions recognized as linear breaks (ero-
sions) at the mucosal surface of the glandular part under a stereo-
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scopic microscope (U10). The extent of the lesion (lesion index) is
expressed as the sum of the length of these breaks per stomach. All
animals received human care in compliance with the guideline of the
Animal Care and Use Committee of Fujita Health University.
2.3. Assays of gastric mucosal MPO
Immediately after gastric mucosal collection, the mucosa was dis-
rupted using a microhomogenizer in 9 volumes of ice-cold 50 mM
Tris-HCl bu¡er (pH 7.5), and the prepared homogenate was sonicated
on ice for 60 s using a Handy Sonic model UR-20P (Tomy Seiko Co.,
Tokyo). The sonicated homogenate was centrifuged at 10 000Ug for
20 min at 4‡C, and the resultant supernatant was used for the assay
sample. Gastric mucosal MPO was assayed by the method of Suzuki
et al. [21] measuring the hydrogen peroxide-dependent oxidation of
tetraethylbenzidine at 37‡C. One unit (U) of this activity is de¢ned as
the amount of enzyme causing a change in absorbance of 1.0 per min
at 655 nm.
2.4. Measurement of NOS activity
Gastric mucosal NOS activity was measured spectrophotometrically
using the oxidation of oxyhaemoglobin to methaemoglobin by NO as
described previously [22,23]. The absorption di¡erence between 401
and 421 nm was continuously monitored with a dual wavelength re-
cording spectrophotometer (Hitachi UV-2000) at 37‡C. For total
NOS assay, the incubation medium contained 1.6 WM oxyhaemoglo-
bin, 200 WM CaCl2, 1 mM MgCl2, 100 WM L-arginine, 100 WM
NADPH, 40 mM potassium phosphate pH 7.2, 1 mM NG-nitro-L-
arginine, and 10% v/v tissue extract with 50 mM L-valine to inhibit
arginase [23]. For cNOS assay, 1 mM EGTA was added to the above
incubation medium without NG-nitro-L-arginine. Oxyhaemoglobin ox-
idation was con¢rmed as being caused by NO synthesis. iNOS activity
was calculated by subtraction of cNOS activity from total NOS ac-
tivity.
2.5. Drug treatment
Rats were injected subcutaneously with L-NMMA (100 mg/kg), its
D-enantiomer, D-NMMA (100 mg/kg) or aminoguanidine (100 mg/
kg), which was dissolved in isotonic saline, at 0.5 h prior to WIR
stress. Control rats were injected subcutaneously with the same vol-
ume of isotonic saline. To determine the speci¢city of L-NMMA, L-
arginine (300 mg/kg) or D-arginine (300 mg/kg) was injected intraper-
itoneally 15 min before L-NMMA administration. Rabbit anti-PMN
antiserum (10 ml/kg), which shows agglutination titer against puri¢ed
rat PMN at 1:256 dilution, was intraperitoneally injected 18 h before
the beginning of the WIR stress. Serum obtained from normal rabbit
was given to control rats in the same manner.
2.6. Statistical analysis
Results obtained are expressed as means þ S.D. Results are ana-
lyzed by computerized statistical packages (SuperANOVA, Statview
II) if necessary. Each mean value is compared by one-way analysis of
variance and Fisher’s protected least signi¢cant di¡erence for multiple
comparisons as the post hoc test. The level of signi¢cance was taken
as P6 0.05.
3. Results
Gastric mucosal lesions developed in rats subjected to WIR
stress over a 6 h period and the magnitude and development
of gastric mucosal lesions in the present study were identical
with those shown in our previous reports [8,13] (Fig. 1A). In
contrast, there were no gastric mucosal lesions in rats without
WIR stress (data not shown). MPO activity, an indicator of
neutrophil in¢ltration [17], in the gastric mucosa of rats sub-
jected to WIR stress for 3 and 6 h signi¢cantly increased (Fig.
1A). Gastric mucosal cNOS activity signi¢cantly decreased in
rats subjected to WIR stress for 3 and 6 h (Fig. 1B). In con-
trast, iNOS activity in the gastric mucosa of rats with WIR
stress for 1, 3, and 6 h signi¢cantly increased in a time-de-
pendent manner (Fig. 1B). However, cNOS and iNOS activ-
ities in the gastric mucosa of control rats without WIR stress
did not change during the experimental period (Fig. 1B).
When L-NMMA (100 mg/kg) with and without either L-
arginine (300 mg/kg) or D-arginine (300 mg/kg), D-NMMA
(100 mg/kg) or aminoguanidine (100 mg/kg) was pretreated to
rats with 3 h of WIR stress, gastric mucosal lesion develop-
ment and gastric mucosal MPO, cNOS, and iNOS activities
were changed as shown in Table 1. Pretreatment with L-
NMMA signi¢cantly enhanced the development of gastric
mucosal lesion in rats subjected to WIR stress for 3 h and
the level of the enhanced gastric mucosal lesions was 181% of
that of the vehicle-treated group, while pretreatment with the
enantiomer, D-NMMA did not augment the lesion develop-
ment. In addition, the enhancement of the development of
gastric mucosal lesion in L-NMMA-pretreated rats with
WIR stress was reversed by exogenous L-arginine, which
was administered 15 min prior to L-NMMA treatment, but
not D-arginine. Pretreatment with aminoguanidine signi¢-
cantly attenuated gastric mucosal lesion development in rats
with 3 h of WIR stress and the level of the attenuated gastric
mucosal lesions was 66% of that of the vehicle-treated group.
Rats without WIR stress showed no gastric mucosal lesions at
3 h after treatment with either L-NMMA or aminoguanidine.
Pretreatment with L-NMMA, but not D-NMMA, signi¢-
cantly enhanced the increase in MPO activity in the gastric
mucosa of rats with 3 h of WIR stress, although this L-
NMMA treatment did not alter gastric mucosal MPO activity
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Fig. 1. Gastric mucosal lesion development and change in MPO ac-
tivity (A), and changes in cNOS and iNOS activities (B) in gastric
mucosal tissues of rats with and without WIR stress over a 6 h pe-
riod. A: Gastric mucosal lesion index (open circle) of rats with
WIR stress, and MPO activity in gastric mucosal tissues of rats
with (shaded bars) and without (open bars) WIR stress were deter-
mined as described in Section 2. B: Assays of cNOS in gastric mu-
cosal tissues of rats with (closed circle) and without (open circle)
WIR stress and of iNOS in gastric mucosal tissues of rats with
(closed triangle) and without (open triangle) WIR stress were per-
formed as described in Section 2. Each value represents the
mean þ S.D. for 5^11 animals. *P6 0.05 compared with rats without
WIR stress.
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in control rats without WIR stress. The enhancement of gas-
tric mucosal MPO activity in WIR-stressed rats with L-
NMMA pretreatment was reversed by exogenous L-arginine,
but not D-arginine. In contrast, an increase in MPO activity in
the gastric mucosa of rats with 3 h of WIR stress was signi¢-
cantly attenuated by pretreatment with aminoguanidine,
although this aminoguanidine treatment did not a¡ect gastric
mucosal MPO activity in control rats without WIR stress.
Furthermore, gastric mucosal cNOS activity in control rats
without WIR stress was signi¢cantly reduced 3 h after pre-
treatment with L-NMMA, but not aminoguanidine. Neither
L-NMMA nor aminoguanidine treatment had any e¡ect on
gastric mucosal iNOS activity in the control rats. An increase
in gastric mucosal iNOS activity in vehicle-treated rats with
WIR stress was dramatically attenuated by pretreatment with
L-NMMA, but not D-NMMA, although the decreased iNOS
activity in the gastric mucosa of L-NMMA-pretreated rats
was still signi¢cantly higher than that in normal rats without
WIR stress. A decrease in gastric mucosal cNOS activity in
vehicle-treated rats with WIR stress was further enhanced by
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Fig. 2. Correlation between either cNOS or iNOS activity and MPO activity in gastric mucosal tissues of WIR-stressed rats without any pre-
treatment (A) and of all WIR-stressed rats with and without pretreatments with NO synthase inhibitors.
Table 1
E¡ect of pretreatment of either L-NMMA or aminoguanidine on gastric mucosal lesion development and changes in gastric mucosal MPO,
cNOS, and iNOS activities in rats with WIR stress
Animals Lesion index (mm) MPO (U/g tissue) cNOS (nmol/min/g tissue) iNOS (nmol/min/g tissue)
Normal control
+Vehicle 0 3.3 þ 0.6 2.5 þ 0.2 0.1 þ 0.1
+L-NMMA 0 3.4 þ 0.5 0.6 þ 0.3 0.1 þ 0.1
+Aminoguanidine 0 3.7 þ 0.4 2.6 þ 0.7 0.1 þ 0.4
WIR (3 h)
+Vehicle 12.0 þ 3.0 7.1 þ 0.8a 1.9 þ 0.5a 2.1 þ 0.3a
+L-NMMA 21.7 þ 7.2b 12.5 þ 4.3a;b 0.4 þ 0.1a;b 0.8 þ 0.2a;b
+D-NMMA 11.2 þ 3.7 7.4 þ 1.0a 2.0 þ 0.2a 2.0 þ 0.9a
+L-NMMA+L-arginine 12.2 þ 3.5 6.9 þ 1.1a 1.3 þ 0.1a;b 0.6 þ 0.2a;b
+L-NMMA+D-arginine 22.2 þ 1.9b 11.6 þ 1.9a;b 0.3 þ 0.2a;b 0.6 þ 0.2a;b
+Aminoguanidine 7.9 þ 1.9b 4.9 þ 0.7a;b 2.5 þ 0.2b 0.2 þ 0.3b
L-NMMA (100 mg/kg), D-NMMA (100 mg/kg) or aminoguanidine (100 mg/kg) was subcutaneously administered to rats 0.5 h before the onset of
WIR stress. The same volume of physiological saline used as a vehicle was given to control rats in the same manner. L-arginine (300 mg/kg) or
D-arginine (300 mg/kg) was intraperitoneally administered to rats 45 min before the onset of WIR stress. Each value represents the mean þ S.D. for
5^11 animals.
aP6 0.05 compared with vehicle-treated rats without WIR stress.
bP6 0.05 compared with vehicle-treated rats with WIR stress.
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pretreatment with L-NMMA, but not D-NMMA. The de-
crease of cNOS activity found in the gastric mucosa of L-
NMMA-pre-administered rats with WIR stress was attenu-
ated by co-pretreatment with L-arginine (P6 0.05). However,
the decrease of gastric mucosal iNOS activity in L-NMMA-
pretreated rats with WIR stress was not changed by co-pre-
treatment with L-arginine and L-NMMA. Co-treatment with
D-arginine and L-NMMA had no e¡ect on the changes of
cNOS and iNOS activities in the gastric mucosa of L-
NMMA-pretreated rats with WIR stress. On the other
hand, an increase in iNOS activity in the gastric mucosa of
vehicle-treated rats with WIR stress was signi¢cantly inhibited
with maintenance of cNOS activity near the normal level by
aminoguanidine pretreatment.
The correlation coe⁄cient between gastric mucosal MPO
activity and either gastric mucosal cNOS or iNOS activity
was 30.633 (P6 0.001) or 0.833 (P6 0.001), respectively, in
rats subjected to WIR stress alone for over a 6 h period (Fig.
2A). When rats received NOS inhibitors and their related
compounds prior to WIR stress, the correlation coe⁄cient
between gastric mucosal MPO activity and either gastric mu-
cosal cNOS or iNOS activity was 30.723 (P6 0.001) or 0.205
(not signi¢cant), respectively.
As shown in Table 2, anti-PMN antiserum pretreatment
prevented the development of gastric mucosal lesions in rats
with 3 h of WIR stress. The activity of gastric mucosal MPO
in anti-PMN antiserum-pretreated rats subjected to 3 h of
WIR stress was signi¢cantly lower than that in rats with nor-
mal rabbit serum pretreatment. Gastric mucosal cNOS activ-
ity in rats subjected to WIR stress for 3 h was not a¡ected by
anti-PMN antiserum pretreatment. In contrast, iNOS activity
in the gastric mucosa of anti-PMN antiserum-pretreated rats
with 3 h of WIR stress was dramatically attenuated compared
with that of normal rabbit serum-pretreated rats with the
same period of WIR stress.
4. Discussion
In this study, we examined whether or not changes in gas-
tric mucosal cNOS and iNOS activities contribute to neutro-
phil in¢ltration into the gastric mucosa of rats with WIR
stress. The neutrophil in¢ltration into the gastric mucosal tis-
sues was checked by MPO activity, because MPO assay has
been widespreadly used as an index of neutrophil in¢ltration
in various experimental gastric injuries [24^31], colitis [32],
and human gastric ulcer [33]. The development of gastric mu-
cosal lesions was found to occur with an increase in gastric
mucosal MPO activity in rats subjected to WIR stress over a
6 h period. Gastric mucosal cNOS activity signi¢cantly de-
creased in rats with 3 and 6 h of WIR stress. In contrast,
iNOS activity in the gastric mucosa of rats subjected to
WIR stress for 1, 3, and 6 h signi¢cantly increased and this
increase in activity occurred time-dependently.
NOS inhibitors such as L-NMMA and L-NAME have been
shown to promote leukocyte-endothelial cell adhesive interac-
tions and leukocyte emigration in postcapillary venules [15].
This NOS inhibitor-induced leukocyte adhesion has also been
shown to be attenuated by L-arginine, a precursor for NO [15]
or nitroprusside, an NO donor [16]. These ¢ndings prompted
us to examine the changes of gastric mucosal cNOS and iNOS
activities and of neutrophil in¢ltration into gastric mucosal
tissues following the development of gastric mucosal lesions
using WIR-stressed rats pretreated with NOS inhibitors. As
reported previously [13], the treatment of L-NMMA, a non-
selective NOS inhibitor [18], but not the enantiomer D-
NMMA, prior to the initiation of WIR stress signi¢cantly
enhanced the development of gastric mucosal lesions with in-
hibition of gastric cNOS and iNOS activities in rats with 3 h
of WIR stress, although the inhibited gastric mucosal iNOS
activity was above the normal level. This pretreatment of L-
NMMA, but not D-NMMA was found to enhance an in-
crease in MPO activity in the gastric mucosa of rats with 3 h
of WIR stress, although this L-NMMA pretreatment had no
e¡ect on the basal gastric mucosal MPO activity in control
rats without WIR stress. Furthermore, the enhancements of
gastric mucosal lesion development and the increase of gastric
mucosal MPO activity in the L-NMMA-pretreated rats with
WIR stress were completely prevented with an incomplete
recovery of inhibited cNOS activity, but not inhibited iNOS
activity, in the gastric mucosa by co-treatment with L-argi-
nine, but not D-arginine. These results suggest that the en-
hancement of an increase in neutrophil in¢ltration associated
with lesion development in the gastric mucosa of L-NMMA-
pretreated rats with WIR stress could be mainly due to an
excessive inhibition of gastric mucosal cNOS activity.
When rats pretreated with aminoguanidine, a selective
iNOS inhibitor [9,19], were subjected to WIR stress for 3 h,
the development of gastric mucosal lesions was incompletely
prevented with a complete recovery of decreased cNOS activ-
ity and a complete inhibition of increased iNOS activity in the
gastric mucosa as reported previously [13]. This pretreatment
of aminoguanidine was found to cause an incomplete inhib-
ition of increased gastric mucosal MPO activity in the WIR-
stressed rats, although this aminoguanidine pretreatment did
not alter gastric mucosal MPO activity in control rats without
WIR stress. These results suggest that an increase in neutro-
phil in¢ltration associated with lesion development in the gas-
tric mucosa of WIR-stressed rats could be, at least in part,
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Table 2
E¡ect of pretreatment of anti-PMN antiserum on gastric mucosal lesion development and changes in gastric mucosal MPO, cNOS and iNOS
activities in rats with WIR stress
Animals Lesion index (mm) MPO (U/g tissue) cNOS (nmol/min/g tissue) iNOS (nmol/min/g tissue)
Normal control 0 3.2 þ 0.3 2.6 þ 0.3 0.1 þ 0.1
WIR (3 h)
+Normal rabbit serum 12.0 þ 2.5 7.2 þ 1.6a 2.0 þ 0.2a 2.1 þ 0.3a
+Anti-PMN antiserum 7.8 þ 2.7b 4.3 þ 0.5b 2.3 þ 0.1a 0.4 þ 0.4b
Rats received i.p. administration of anti-polymorphonuclear leukocyte (PMN) antibody (10 ml/kg) 18 h prior to the onset of WIR stress. Rats
without anti-PMN pretreatment received i.p. administration of an equal volume of normal rabbit serum. These rats were subjected to WIR stress
for 3 h. Each value represents the mean þ S.D. for 7^10 animals.
aP6 0.05 compared with normal control rats without WIR stress.
bP6 0.05 compared with WIR-stressed rats with normal rabbit serum pretreatment.
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related to a decrease in gastric mucosal cNOS activity and/or
an increase in gastric mucosal iNOS activity.
We further attempted to check the correlation between
MPO activity and either cNOS or iNOS activity in the gastric
mucosa of WIR-stressed rats with and without pretreatment
of either L-NMMA (with and without L-arginine or D-argi-
nine), D-NMMA or aminoguanidine. A relatively good neg-
ative correlation between MPO activity and cNOS activity
was found in the gastric mucosa of all WIR-stressed rats
with and without each pretreatment. This ¢nding suggests
that in rats with WIR stress, a decrease in gastric mucosal
cNOS activity could facilitate neutrophil in¢ltration into the
gastric mucosa, resulting in the development of gastric mu-
cosal lesions. Accordingly, it seems that maintenance of cNOS
activity in gastric mucosal tissues contributes to the preven-
tion of neutrophil in¢ltration into the tissue. In addition, a
de¢nite positive correlation between MPO activity and iNOS
activity was observed in the gastric mucosa of WIR-stressed
rats without any pretreatment. From this ¢nding, one can
assume that an increase in iNOS activity in gastric mucosal
tissues contributes to an increase in neutrophil in¢ltration into
the tissue. However, no correlation between MPO activity and
iNOS activity was found in the gastric mucosa of all WIR-
stressed rats with and without each pretreatment, suggesting
no contribution of increased gastric mucosal iNOS to the
increase of neutrophil in¢ltration into the gastric mucosa of
rats with WIR stress.
As afore-mentioned, gastric mucosal iNOS and MPO activ-
ities showed a similar increase during the development of
gastric mucosal lesions in rats with WIR stress. The source
of increased iNOS in the gastric mucosa of rats with WIR
stress is still unclear at present. But, it has been reported that
iNOS is induced in activated neutrophils [34,35]. From these
¢ndings, it seems likely that a part of the increase of iNOS
activity found in the gastric mucosa of rats with WIR stress is
due to activated neutrophils in¢ltrated into the tissue. There-
fore, we attempted to clarify whether or not neutrophil in¢l-
tration into the gastric mucosa of rats with WIR stress con-
tributes to an increase in iNOS activity in the tissue and this
contribution is associated with the development of gastric
mucosal lesions. Namely, we examined the e¡ect of pretreat-
ment of anti-PMN antiserum on the development of gastric
mucosal lesions and the changes of gastric mucosal MPO,
cNOS, and iNOS activities in rats subjected to WIR stress
for 3 h. Pretreatment with anti-PMN antiserum attenuated
the development of gastric mucosal lesions with prevention
of an increase in gastric mucosal MPO activity in the WIR-
stressed rats as shown in our previous report [8]. In addition,
this pretreatment of anti-PMN antiserum prevented an in-
crease in gastric mucosal iNOS activity without a¡ecting a
decrease in gastric mucosal cNOS activity in the WIR-stressed
rats. These results indicate that neutrophil in¢ltration into the
gastric mucosa of rats with WIR stress contributes to an in-
crease in iNOS activity in the tissue, resulting in the develop-
ment of gastric mucosal lesions, and suggest that activated
neutrophils in¢ltrated into the gastric mucosa of WIR-stressed
rats could be one of the sources of iNOS increasing in the
tissue. However, a signi¢cant increase in iNOS activity in the
gastric mucosa of rats subjected to 1 h of WIR stress was
found without a signi¢cant increase in MPO activity in the
gastric mucosal tissue at this time point. Therefore, another
source of iNOS induction except neutrophils should be asso-
ciated with the increase in iNOS activity found in the gastric
mucosa of rats with 1 h of WIR stress.
Gastric peroxidase has been puri¢ed and characterized [36],
and this enzyme exists in rats gastric parietal cells and the
other mucosal cells [37]. It has been reported that in rats
with cold restraint stress which is essentially the same as
WIR stress, gastric peroxidase activity time-dependently de-
creases through the oxygen free radical-mediated inactivation
of the enzyme [38,39]. We have reported that generation of
oxygen free radical is closely related to the development of
gastric mucosal lesions in rats with WIR stress [8]. Accord-
ingly, it can be thought that a decrease in gastric peroxidase
activity should occur in rats with WIR stress. In this study,
however, gastric mucosal MPO activity increased with the
development of gastric mucosal lesions in rats with WIR
stress, and the increase in activity was attenuated when rats
with anti-PMN antiserum pretreatment were subjected to
WIR stress. The ¢ndings may allow us to think that increased
MPO activity in the gastric mucosa of rats with WIR stress
corresponds to neutrophil-related peroxidase activity.
In conclusion, the results obtained in this study indicate
that in rats with WIR stress, a decrease in cNOS activity,
but not an increase in iNOS activity, in the gastric mucosa
contributes to an increase in neutrophil in¢ltration into the
tissue, resulting in the development of gastric mucosal lesions
and that neutrophil in¢ltration into the gastric mucosa of
WIR-stressed rats contributes to an increase in iNOS activity
in the tissue. The present results also suggest that NO synthe-
sized by gastric mucosal cNOS could play an inhibitory role
in neutrophil in¢ltration into gastric mucosal tissues and that
activated neutrophils in¢ltrated into gastric mucosal tissues
could be one of the sources of iNOS increasing in the tissue.
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